Toho Holdings Co Ltd - Company Profile
Powered by 
All the sales intelligence you need on Toho Holdings Co Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Toho Holdings Co Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Toho Holdings Co Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Toho Holdings Co Ltd (Toho) is a wholesaler of pharmaceutical products engaged in the medical, health, and nursing care sectors. The company's main activities include pharmaceutical wholesaling, dispensing pharmacy operations, and the manufacturing and sales of pharmaceuticals, particularly focusing on generic drugs. The company is associated with brands such as Kyoso Mirai Group in Pharmacy and Mirai Research Institute. Its products and services cater to medical institutions, pharmacies, and home-visit nursing stations, supporting community healthcare and pharmaceutical distribution. The company utilizes advanced technologies in its logistics systems to ensure the secure and efficient delivery of pharmaceuticals. Toho operates through a network of subsidiaries and partners. The company serves various geographic markets, focusing on enhancing local healthcare services. Toho is headquartered in Tokyo, Japan.
Headquarters
Japan
Address
4-43-11 Daizawa, Setagaya, Tokyo, 155-8655
Website
www.tohohd.co.jp
Telephone
81 6 64520785
No of Employees
7,675
Industry
Wholesale
Ticker Symbol & Exchange
8129 (TYO)
Revenue (2025)
$10.0B
2.3%
(2025 vs 2024)
EPS
XYZ
Net Income (2025)
XYZ
-12.7%
(2025 vs 2024)
Market Cap*
$1.8B
Net Profit Margin (2025)
XYZ
-14.5%
(2025 vs 2024)
* As of and is in US$
Toho Holdings Co Ltd premium industry data and analytics
Products and Services
| Products | Services |
|---|---|
| Prescription Pharmaceuticals | Wholesaling Pharmaceuticals: |
| Injection drugs | Logistics System |
| Customer Support System | |
| XYZ | |
| XYZ | |
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | Divestiture | In July, the company, BCP Asia AYM Holding (Cayman) LP, and Hisamitsu Pharmaceutical Co Ltd sold a 100% stake in Ayumi Pharmaceutical Holdings Co., Ltd to GNI Group Ltd. |
| 2026 | Contracts/Agreements | In April, the company, the National Institute of Advanced Industrial Science and Technology, and AIST Solutions Co., Ltd. introduced the Toho Holdings-AIST New Modality Transport Technology Co-creation Project. |
| 2025 | Contracts/Agreements | In May, the company and MTI Healthcare Holdings Inc. entered into an agreement to acquire a 30.30% stake in Pharmo Inc. from MTI Ltd. |
Competitor Comparison
| Key Parameters | Toho Holdings Co Ltd | Alfresa Holdings Corp | Suzuken Co Ltd | Otsuka Holdings Co Ltd | Astellas Pharma Inc |
|---|---|---|---|---|---|
| Headquarters | Japan | Japan | Japan | Japan | Japan |
| City | Setagaya | Chiyoda-Ku | Nagoya | Minato | Chuo-Ku |
| State/Province | Tokyo | Tokyo | Aichi | Tokyo | Tokyo |
| No. of Employees | 7,675 | 12,452 | 12,923 | 37,758 | 13,643 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Hiromi Edahiro | Chief Executive Officer; President; Director | Executive Board | 2024 | 74 |
| Akira Umada | Chief Operating Officer; Senior Executive Managing Director | Executive Board | 2022 | 61 |
| Takeo Matsutani | Chief Growth Officer; Managing Director | Executive Board | 2009 | 60 |
| Shuzo Kono | Director; Corporate Officer- in charge of transformation | Executive Board | 2022 | 48 |
| Yasuo Sakae | Corporate Officer; Chief Financial Officer | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer